| Pregnancy |
1 |
1 |
| Premature Birth |
0 |
0.62 |
| Birth |
0 |
0.54 |
| Multiple Birth |
0 |
0.43 |
| Twin-Twin Transfusion Syndrome |
0 |
0.38 |
| Anemia |
0 |
0.27 |
| Fetal Growth Restriction |
0 |
0.27 |
| Polycythemia |
0 |
0.27 |
| Transfusion |
0 |
0.27 |
| Face |
0 |
0.2 |
| Preeclampsia |
0 |
0.2 |
| Radiofrequency Ablation |
0 |
0.18 |
| Genetic Testing |
0 |
0.14 |
| Ablation |
0 |
0.13 |
| Genetics |
0 |
0.13 |
| Postpartum Hemorrhage |
0 |
0.13 |
| Premature Rupture of Membranes (PROM) |
0 |
0.13 |
| Prenatal Screening and Diagnostics |
0 |
0.12 |
| Assisted Reproductive Technology |
0 |
0.1 |
| Genomic Medicine |
0 |
0.1 |
| Amniocentesis |
0 |
0.07 |
| Anatomy |
0 |
0.07 |
| Body Mass Index |
0 |
0.07 |
| Cardiovascular Imaging |
0 |
0.07 |
| Echocardiography |
0 |
0.07 |
| Fellowship |
0 |
0.07 |
| Gestational Age |
0 |
0.07 |
| Heart |
0 |
0.07 |
| Hemorrhage |
0 |
0.07 |
| In Vitro Fertilization |
0 |
0.07 |
| Laser |
0 |
0.07 |
| Maternal-Fetal Medicine |
0 |
0.07 |
| Meta-Analysis |
0 |
0.07 |
| Microarray Technologies |
0 |
0.07 |
| New York |
0 |
0.07 |
| Postpartum |
0 |
0.07 |
| Reproduction Technology |
0 |
0.07 |
| Ultrasonography |
0 |
0.07 |
| Infertility Female |
0 |
0.06 |